diabetes glp-1 vs sglt2 GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes Cardiovascular benefits of SGLT2 inhibitors

Obesity is a major driver of both diabetes and cardiovascular disease, and contributes to 50 percent of cancer deaths, according to the American Cancer Society

You won't necessarily feel a surge of energy the moment you take your first dose

These changes lead to deletions, translocations, point mutations, or insertions

PMID: 29634344

Unable to be remethylated, homocysteine accumulates

Tips to Support Exercise While Using GLP-1 Medications If youre taking a GLP-1 medication and want to stay active (which I strongly encourage), here are some strategies: Eat with Intention Even if youre not hungry, fuel your workouts with light, balanced meals or snacks that include carbs and protein